Miami Cancer Center

Miami, Florida 33176

1 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Gliomas, Locally Advanced Pancreatic Cancer, Metastatic Androgen Independent Prostate Cancer, Prostate Cancer, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Studies at this site

• Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy — Recruiting now
• Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC — Recruiting now
• Nivolumab for Recurrent or Progressive IDH Mutant Gliomas — Completed
• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed